CAR-T CELL DYNAMICS ARE ASSOCIATED WITH CLINICAL OUTCOME IN PATIENTS TREATED WITH ANTI-CD19 CAR-T CELL THERAPY FOR RELAPSED/REFRACTORY B-CELL MALIGNANCIES: A REAL-LIFE COHORT STUDY

被引：0
|
作者：
Noviello, Maddalena [1 ]
De Felice, Francesco [1 ]
Bergonzi, Gregorio Maria [2 ]
Valtolina, Veronica [1 ]
Angelillo, Piera [1 ]
Greco, Raffaella [1 ]
Xue, Elisabetta [1 ]
Campodonico, Edoardo [1 ]
Lupo-Stanghellini, Maria Teresa [1 ]
Somai, Francesca [1 ,2 ]
Falcone, Laura [1 ]
Beretta, Valeria [1 ]
Tassi, Elena [1 ]
Peccatori, Jacopo [1 ]
Casucci, Monica [1 ]
Carrabba, Matteo [1 ]
Ciceri, Fabio [1 ,2 ]
Bonini, Chiara [1 ,2 ]
机构：
[1] IRCCS Osped San Raffaele, Milan, Italy
[2] Univ Vita Salute San Raffaele, Milan, Italy
来源：
BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / SUPP1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P081
引用
收藏
页码：206 / 207
页数：2
相关论文
共 50 条
  • [21] The Impact of Bridging Therapy Prior to CAR-T Cell Therapy on Clinical Outcomes of Patients with Relapsed Refractory Large B-Cell Lymphoma
    Lutfi, Forat
    Kansagra, Ankit
    Ali, Moaath Mustafa
    Bukhari, Ali
    Siglin, Jonathan
    Yan, Jingsheng
    Samanta, Santanu
    Holtzman, Noa G.
    Gottlieb, David
    Kim, Dong Won
    Lee, Seung-Tae
    Kocoglu, Mehmet Hakan
    Yared, Jean A.
    Hardy, Nancy M.
    Molitoris, Jason
    Mohindra, Pranshu
    Rapoport, Aaron P.
    Dahiya, Saurabh
    [J]. BLOOD, 2020, 136
  • [22] Tisagenlecleucel: CAR-T Cell Therapy for B-cell Lymphoma
    Andres, Ulrike
    [J]. TRANSFUSIONSMEDIZIN, 2019, 9 (02)
  • [23] Multi Targeted CAR-T Cell Therapies for B-Cell Malignancies
    Shah, Nirav N.
    Maatman, Theresa
    Hari, Parameswaran
    Johnson, Bryon
    [J]. FRONTIERS IN ONCOLOGY, 2019, 9
  • [24] Translating anti-CD19 CAR T-cell therapy into clinical practice for relapsed/refractory diffuse large B-cell lymphoma
    Chow, Victor A.
    Shadman, Mazyar
    Gopal, Ajay K.
    [J]. BLOOD, 2018, 132 (08) : 777 - 781
  • [25] Predictive model for CAR-T cell therapy success in patients with relapsed/refractory B-cell acute lymphoblastic leukaemia
    Pu, Lianfang
    Wang, Huiping
    Wu, Fan
    An, Furun
    Xiao, Hao
    Wang, Yangyang
    Liang, Xue
    Zhai, Zhimin
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2024, 99 (04)
  • [26] CD19/CD22 CAR-T Cell Cocktail Therapy Following Autologous Transplantation in Patients with Relapsed/Refractory B-Cell Lymphomas
    Cao, Yang
    Xiao, Yi
    Wang, Na
    Wang, Gaoxiang
    Zhou, Xiaoxi
    Huang, Liang
    Chen, Liting
    Xiao, Min
    Zhang, Tongcun
    Zhang, Yicheng
    Zhou, Jianfeng
    [J]. BLOOD, 2020, 136
  • [27] Incidence and prophylaxis of herpes zoster in relapsed or refractory B-cell lymphoma patients after CD19-specific CAR-T cell therapy
    Liu, Hui
    Li, Ping
    Zhao, Aiqi
    Lei, Wen
    Liang, Aibin
    Qian, Wenbin
    [J]. LEUKEMIA & LYMPHOMA, 2022, 63 (04) : 1001 - 1004
  • [28] Response to Mosunetuzumab in Patients with B-Cell Lymphomas Relapsed or Refractory after CAR-T Cell Therapy Is Associated with Changes in Lymphocyte Counts
    Chong, Elise A.
    Penuel, Elicia
    Bartlett, Nancy L.
    Bosch, Francesc
    Budde, L. Elizabeth
    Fay, Keith
    Flinn, Ian W.
    Goy, Andre
    Kumar, Anita
    Lundberg, Rachel
    Napier, Ellen B.
    Nastoupil, Loretta J.
    Shadman, Mazyar
    Wei, Michael C.
    Wu, Mei
    Yin, Shen
    Chong, Emeline R.
    Schuster, Stephen J.
    [J]. BLOOD, 2023, 142
  • [29] A Feasibility and Safety Study of Non-Viral Genome Targeting Anti-CD19 CAR-T in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
    Wang, Yi
    Wang, Hui
    Gao, Ying
    Zhang, Ding
    Zheng, Yan
    Hu, Xingxing
    Gao, Qiuying
    Peng, Zuohan
    Li, Le
    Niu, Ben
    Hou, Limin
    Wang, Ling
    Zhang, Weihua
    Zhang, Yi
    Ru, Xingli
    [J]. BLOOD, 2020, 136
  • [30] Selecting the Optimal CAR-T for the Treatment of B-Cell Malignancies
    Taha Al-Juhaishi
    Sairah Ahmed
    [J]. Current Hematologic Malignancy Reports, 2021, 16 : 32 - 39
12345